← Eichor
Condition: Refractory Rheumatoid Arthritis Ra Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Refractory Rheumatoid Arthritis Ra

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

A Clinical Study of YTS109 Cell in R/R Autoimmune Diseases
Phase 1 · 1 location(s) · China Immunotech (Beijing) Biotechnology Co., Ltd. · NCT06978647A Study of Healthy Donor CD19-targeted Allogeneic CAR T Cells in Participants With Severe, Refractory Autoimmune Disease
Phase 1 · 28 location(s) · Juno Therapeutics, Inc., a Bristol-Myers Squibb Company · NCT07115745The Clinical Study on the Treatment of Refractory RA With UTAA91 Injection
EARLY_Phase 1 · 1 location(s) · Union Hospital, Tongji Medical College, Huazhong University · NCT07001956AlloNK®, an Allogeneic Non-genetically Modified, Cord Blood-derived NK Cell Therapy, in Combination With Rituximab, Stud
Phase 2 · 52 location(s) · Artiva Biotherapeutics, Inc. · NCT06991114At-home Ultrasound Localized Therapy for Rheumatoid Arthritis Study [At-home ULTRA Study]
NA · 5 location(s) · SecondWave Systems Inc. · NCT07163221Safety Study of CC312 in Autoimmune Disease Patients
EARLY_Phase 1 · 1 location(s) · CytoCares Inc · NCT06888960A Long-Term Follow-Up Study for Participants Previously Treated With KYV-101
Phase N/A · 1 location(s) · Kyverna Therapeutics · NCT07403188A Phase 1 Study of ADI-001 in Rheumatoid Arthritis
Phase 1 · 1 location(s) · Adicet Therapeutics · NCT07100873An Open-label Study of Cizutamig in Refractory Seropositive Rheumatoid Arthritis
Phase 1 · 1 location(s) · Union Hospital, Tongji Medical College, Huazhong University · NCT06946199A Study of CLN-978, a Subcutaneously Administered CD19-directed T Cell Engager, in Subjects With Rheumatoid Arthritis
Phase 1 · 3 location(s) · Cullinan Therapeutics Inc. · NCT06994143Integrated Clinical Study of Traditional Chinese and Western Medicine for Refractory Rheumatoid Arthritis
Phase 4 · 1 location(s) · Shanghai Guanghua Hospital of Integrated Traditional Chinese · NCT07721142A Study to Assess Safety, Cellular Kinetics and Exploratory Efficacy of Rapcabtagene Autoleucel in Rheumatoid Arthritis
Phase 1/Phase 2 · 12 location(s) · Novartis Pharmaceuticals · NCT07048197Efficacy and Safety of Telitacicept Combined With Baricitinib for Refractory Rheumatoid Arthritis
Phase N/A · 1 location(s) · Zhejiang Provincial People's Hospital · NCT07491016Phase 1 Study of HBI0101 CAR-T in Refractory B-Cell Autoimmune Diseases
Phase 1 · 1 location(s) · Polina Stepensky · NCT07085676
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.